Cleared Traditional

K971690 - IMMUNOSCAN PR3-ANCA

K971690 is an FDA 510(k) clearance for IMMUNOSCAN PR3-ANCA, manufactured by Euro-Diagnostica AB. The device is a Class 2 Immunology device with product code MOB cleared through the Traditional 510(k) pathway after a 175-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1997
Decision
175d
Days
Class 2
Risk

K971690 is an FDA 510(k) clearance for the IMMUNOSCAN PR3-ANCA. Classified as Test System, Antineutrophil Cytoplasmic Antibodies (anca) (product code MOB), Class II - Special Controls.

Submitted by Euro-Diagnostica AB (Ringoes, US). The FDA issued a Cleared decision on October 29, 1997 after a review of 175 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Euro-Diagnostica AB devices

FDA 510(k) Submission Details - K971690

510(k) Number K971690 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 07, 1997
Decision Date October 29, 1997
Days to Decision 175 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
70d slower than avg
Panel avg: 105d · This submission: 175d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MOB Device Classification - Class 2, Special Controls

Product Code MOB Test System, Antineutrophil Cytoplasmic Antibodies (anca)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - MOB Test System, Antineutrophil Cytoplasmic Antibodies (anca)

All 50
Devices cleared under the same product code (MOB) and FDA review panel - the closest regulatory comparables to K971690.
PR 3 ANTIBODY KIT
K973823 · Hemagen Diagnostics, Inc. · Nov 1997
VIRGO PANCO KIT
K973824 · Hemagen Diagnostics, Inc. · Nov 1997
IMMUNOSCAN ANTI-MYELOPEROXIDASE ANTIBODIES (MPO-ANCA) QUANTITATIVE KIT
K971689 · Euro-Diagnostica AB · Oct 1997
ANCA COMBI DIAGNOSTIC TEST KIT
K965133 · The Binding Site, Ltd. · May 1997
MYELOPEROXIDASE ELISA TEST SYSTEM
K964446 · Zeus Scientific, Inc. · Apr 1997
PROTEINASE-3 IGG ELISA TEST SYSTEM
K964448 · Zeus Scientific, Inc. · Apr 1997